SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / ORD SHS
Total 13F shares
25,143,303
Share change
+387,750
Total reported value
$193,353,144
Price per share
$7.69
Number of holders
60
Value change
+$3,384,017
Number of buys
23
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q2 2016

As of 30 Jun 2016, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,143,303 shares. The largest 10 holders included Senvest Management, LLC, NORTH TIDE CAPITAL, LLC, BRANDES INVESTMENT PARTNERS, LP, JPMORGAN CHASE & CO, Camber Capital Management LLC, DALTON GREINER HARTMAN MAHER & CO, RENAISSANCE TECHNOLOGIES LLC, Ion Asset Management Ltd., Migdal Insurance & Financial Holdings Ltd., and ROYCE & ASSOCIATES LP. This page lists 60 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.